Strategic and results-driven Medical Affairs professional with expertise in hematology-oncology, solid tumors, ophthalmology, and rheumatology. Proven ability to engage Key Opinion Leaders (KOLs), clinical experts, and scientific thought leaders to drive medical strategy and evidence generation. Adept at delivering scientific presentations, coordinating clinical trials, developing educational materials, and analyzing study data.
Solid Tumor Oncology
Hematology & Oncology Biosimilars
Key Achievement: Winner of the 2020 North American Medical Affairs Award
Ophthalmology
Division of Basic Sciences
1. Scarlett KA, White EZ, Coke CJ, et al. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration. Molecular Cancer Research. 2018;16(4):728-739.
2. Coke CJ, Scarlett KA, Jones KJ, et al. Simultaneous Activation of CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Cancer Cell Metastasis Regulation. J Biol Chem. 2016;291(19):9991-10005.
3. Scarlett KA, Pattabiraman V, Barnett P, et al. The Proangiogenic Effect of Iroquois Homeobox Transcription Factor Irx3 in Human Microvascular Endothelial Cells. J Biol Chem. 2015;290(10):6303-6315.